Comparison of Comfilcon A Toric Contact Lenses and Samfilcon A Toric Contact Lenses

December 17, 2019 updated by: CooperVision, Inc.

A Bilateral Dispensing Comparison of Biofinity Toric and Ultra for Astigmatism

The objective of this study is to evaluate the subjective acceptance of comfilcon A toric contact lens, compared to samfilcon A toric lens.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Is at least 17 years of age and has full legal capacity to volunteer;
  • Has had a self-reported oculo-visual examination in the last two years.
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Is an adapted soft contact lens wearer, who currently wears contact lenses for a minimum 3 days/week and 8 hours/day AND who anticipates no difficulty wearing CLs for 6 days/week, 10 hours /day.
  • Is willing to wear contact lens in both eyes for the duration of the study;
  • Has a minimum astigmatism of - 0.75, determined by refraction;
  • Can be fit with the two study contact lens types in the powers available;
  • Has a distance visual acuity of 0.20 logMAR (approx 20/30) or better, determined by refraction;
  • Can achieve a distance visual acuity of 0.20 logMAR (approx 20/30) or better in each eye with the study contact lenses.
  • Has clear corneas and no active* ocular disease

Exclusion Criteria:

  • Is participating in any concurrent clinical trial;
  • Has any known active* ocular disease and/or infection;
  • Has a systemic condition that in the opinion of the investigator may affect a study measure;
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure;
  • Has known sensitivity to fluorescein dye or products to be used in the study;
  • Appears to have any active* ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses;
  • Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
  • Is aphakic;
  • Has undergone refractive error surgery.
  • Has participated in the PIANO (i.e. EX-MKTG-83) Study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: comfilcon A toric lens
Subjects who wear comfilcon A toric lens either as first or second pair during this cross-over study.
Contact lens
Other Names:
  • test lens
  • Biofinity toric
Contact lens
Other Names:
  • Ultra for Astigmatism
  • control lens
Active Comparator: samfilcon A toric lens
Subjects who wear samfilcon A toric lens either as first or second pair during this cross-over study.
Contact lens
Other Names:
  • test lens
  • Biofinity toric
Contact lens
Other Names:
  • Ultra for Astigmatism
  • control lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort at Insertion
Time Frame: Dispense
Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)
Dispense
Comfort
Time Frame: 2 weeks
Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)
2 weeks
Comfort
Time Frame: 1-month
Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)
1-month
Lens Preference Based on Overall Comfort
Time Frame: 1 month
Lens preference with respect to comfort (Prefer pair-1 strongly, Prefer pair-1 slightly, Prefer pair-2 strongly, prefer pair-2 slightly, No preference)
1 month
Lens Preference Based on Overall Dryness
Time Frame: 1 month
Lens preference with respect to dryness (Prefer pair-1 strongly, Prefer pair-1 slightly, Prefer pair-2 strongly, prefer pair-2 slightly, No preference)
1 month
Dryness
Time Frame: 2 weeks
Subjective ratings of dryness for each pair of lenses (scale: 0-10; 0=Extremely dry, 10=No dryness)
2 weeks
Dryness
Time Frame: 1-month
Subjective ratings of dryness for each pair of lenses (scale: 0-10; 0=Extremely dry, 10=No dryness)
1-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of Insertion
Time Frame: Dispense
Subjective rating of ease of inserting the lens onto the eye (scale 0-10; 0=very difficult, 10=very easy)
Dispense
Ease of Insertion
Time Frame: 2-weeks
Subjective rating of ease of inserting the lens onto the eye (scale 0-10; 0=very difficult, 10=very easy)
2-weeks
Ease of Insertion
Time Frame: 1-month
Subjective rating of ease of inserting the lens onto the eye (scale 0-10; 0=very difficult, 10=very easy)
1-month
Ease of Removal
Time Frame: 2-weeks
Subjective rating of ease of removing the lens from the eye (scale 0-10; 0=very difficult, 10=very easy)
2-weeks
Ease of Removal
Time Frame: 1 month
Subjective rating of ease of removing the lens from the eye (scale 0-10; 0=very difficult, 10=very easy)
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lyndon Jones, PhD FCOptom, Director, Centre for Ocular Research & Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2018

Primary Completion (Actual)

October 15, 2018

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

May 1, 2018

First Submitted That Met QC Criteria

May 1, 2018

First Posted (Actual)

May 9, 2018

Study Record Updates

Last Update Posted (Actual)

January 6, 2020

Last Update Submitted That Met QC Criteria

December 17, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-91

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on comfilcon A toric lens

Subscribe